重大事件
外國發行人報告
6-K
2026-07-23
Nano X Imaging 提交6-K，確認可透過ATM計劃發行剩餘5390萬美元普通股
AI 繁中摘要
📄 **Nano-X Imaging（納斯達克代碼：NNOX）提交 6-K 表格**
日期：2026 年 7 月 23 日
是次申報主要為附上一份以色列律師事務所 Meitar Law Offices 出具的法律意見書，確認公司根據 ATM（市價發行）計劃可發行及出售剩餘 **5,390 萬美元** 普通股（每股面值 NIS 0.01）的合法性。
該 ATM 計劃基於公司與 Cantor Fitzgerald & Co. 及 Mizuho Securities USA LLC 於 2024 年 6 月 7 日簽訂的《Controlled Equity OfferingSM 銷售協議》，並配合 2026 年 3 月 13 日提交、經修訂後於 3 月 30 日生效的 F-3 儲架註冊聲明，以及 2026 年 7 月 23 日提交的招股說明書補充文件。
是次 6-K 的內容（包括法律意見書及銷售協議）已被納入上述 F-3 註冊聲明及招股說明書補充中。
**對投資者的潛在影響** 💡
公司繼續透過 ATM 機制籌集資金，反映其資本市場集資渠道暢順，但同時可能稀釋現有股東權益。投資者宜留意後續發行節奏及資金用途。
（本摘要僅供參考，不構成任何買賣建議。）
展開英文正文
6-K 1 ea0298677-6k_nanox.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2026 Commission File Number: 001-39461 NANO-X IMAGING LTD (Translation of registrant’s name into English) Ofer Tech Park 94 Shlomo Shmeltzer Road Petach Tikva Israel 4970602 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☑ Form 40-F ☐ CONTENTS Legal Opinion as to Validity of Shares Under ATM Offering NANO-X IMAGING LTD (the “Company”) is filing this Report of Foreign Private Issuer on Form 6-K (this “Form 6-K”) solely to file as an exhibit the legal opinion of Meitar Law Offices, Israeli counsel to the Company, relating to the validity of the remaining $53.9 million of the Company’s ordinary shares, par value NIS 0.01 per share, that may be issued and sold from time to time hereafter (the “Shares”) under the Controlled Equity OfferingSM Sales Agreement, dated June 7, 2024, by and between the Company and Cantor Fitzgerald & Co. and Mizuho Securities USA LLC, as sales agents, and pursuant to the Company’s shelf registration statement on Form F-3 (File No. 333-294302) filed with the Securities and Exchange Commission (the “SEC”) on March 13, 2026, as amended by Amendment No. 1 thereto filed on March 26, 2026, and declared effective by the SEC on March 30, 2026 (the “Form F-3”), and a prospectus supplement, dated July 23, 2026, filed by the Company with the SEC pursuant to Rule 424(b)(5) under the Securities Act of 1933 on July 23, 2026 (the “Prospectus Supplement”) (which supplements the prospectus in the Form F-3), as the same may be amended or supplemented. A copy of that legal opinion serves as Exhibit 5.1 to this Form 6-K. This Form 6-K does not constitute an offer to sell or the solicitation of an offer to buy any of the Shares. Exhibits Exhibit No. Exhibit 5.1 Legal opinion of Meitar Law Offices, Israeli counsel to the Company, as to the validity of the Shares to be sold under the Prospectus Supplement 10.1 Sales Agreement, dated as of June 7, 2024, among the Company, Cantor Fitzgerald & Co., and Mizuho Securities USA LLC. (incorporated by reference to Exhibit 10.1 to the Company’s Report of Foreign Private Issuer on Form 6-K furnished to the SEC on June 7, 2024) Incorporation by Reference The contents of this Form 6-K, including Exhibits 5.1 and 10.1 hereto, are hereby incorporated by reference into the Form F-3 and the Prospectus Supplement. 1 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. NANO-X IMAGING LTD By: /s/ Erez Meltzer Name: Erez Meltzer Title: Chief Executive Officer and Acting Chairman of the Board Date: July 23, 2026 2